Get The App!
Loading the player...
Heterogeneity of Stage III NSCLC
Share by Email
Send to social websites
Report this video as inappropriate
You can report this video if you think it to be inappropriate, we will review your submission soon. If your reason is not listed here, like copyright infringements, please contact us directly by email.
Select your reason
Violent or Repulsive Content
Hateful or Abusive Content
Harmful Dangerous Acts
Dr. Mark A. Socinski, MD, University of Pittsburgh School of Medicine, discusses heterogeneity of stage III NSCLC, filmed at IASLC 2015.
Managing 3 Compartments in Stage III NSCLC: Local Disease, Distant Disease, and the CNS
Serum Tumor Markers in Management of Lung Cancer
What is Next Gen Sequencing?
Basics of Working up Lung Cancer
Pulmonary Function Tests: What are They, and What are They For?
PET Scan Imaging: What Does it Tell us?
Need for a Biopsy and How a Diagnosis of Lung Cancer is Made
Potential Advantages of Lung Cancer Screening
Copyright 2020 by NSCI Group, Inc.
On The Go
About MedEd On The Go